{"organizations": [], "uuid": "042d38cfba30feb679cde76852bae622b4553877", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-casi-pharmaceuticals-announces-50/brief-casi-pharmaceuticals-announces-50-million-private-placement-idUSASC09T03", "country": "US", "domain_rank": 408, "title": "BRIEF-CASI Pharmaceuticals Announces $50 Million Private Placement", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-20T15:34:00.000+02:00", "replies_count": 0, "uuid": "042d38cfba30feb679cde76852bae622b4553877"}, "author": "", "url": "https://www.reuters.com/article/brief-casi-pharmaceuticals-announces-50/brief-casi-pharmaceuticals-announces-50-million-private-placement-idUSASC09T03", "ord_in_thread": 0, "title": "BRIEF-CASI Pharmaceuticals Announces $50 Million Private Placement", "locations": [], "entities": {"persons": [], "locations": [{"name": "china", "sentiment": "none"}], "organizations": [{"name": "brief-casi pharmaceuticals", "sentiment": "negative"}, {"name": "ivate placement reuters", "sentiment": "none"}, {"name": "casi pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 20, 2018 / 1:34 PM / Updated 7 minutes ago BRIEF-CASI Pharmaceuticals Announces $50 Million Private Placement Reuters Staff March 20 (Reuters) - Casi Pharmaceuticals Inc: * CASI PHARMACEUTICALS ANNOUNCES $50 MILLION PRIVATE PLACEMENT TO PREPARE COMPANY FOR COMMERCIALIZATION IN CHINA * CASI PHARMACEUTICALS INC - ‍ON MARCH 19, 2018, CONSOLIDATED CLOSING BID PRICE PER SHARE OF COMMON STOCK WAS $3.19​ * CASI PHARMACEUTICALS - ENTERED INTO DEFINITIVE SECURITIES PURCHASE AGREEMENTS PURSUANT TO WHICH CO WILL ISSUE 15.4 MILLION SHARES OF COMMON STOCK Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-20T15:34:00.000+02:00", "crawled": "2018-03-20T15:48:27.023+02:00", "highlightTitle": ""}